Cover Image

Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients

Saved in:

Bibliographic Details
Main Authors:	Mehrdad Solati (Author), Hamid-Reza Mahboobi (Author)
Format:	Book
Published:	Society of Diabetic Nephropathy Prevention, 2012-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Paraoxonase-1 Regulation of Renal Inflammation and Fibrosis in Chronic Kidney Disease
by: Fatimah K. Khalaf, et al.
Published: (2022)

Activity of the antioxidant enzyme paraoxonase in Argentinean children living at high altitude
by: V. Hirschler, et al.
Published: (2018)

Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson's Disease
by: Boštjan Petrič, et al.
Published: (2023)

Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease
by: Hyo Jin Kang, et al.
Published: (2013)

A PON for All Seasons: Comparing Paraoxonase Enzyme Substrates, Activity and Action including the Role of PON3 in Health and Disease
by: Chrysan J. Mohammed, et al.
Published: (2022)

Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis
by: Jun Watanabe, et al.
Published: (2021)

Serum arylesterase and paraoxonase activities in patients with ovarian tumors
by: Slawomir Michalak, et al.
Published: (2014)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
by: Angelo Zinellu, et al.
Published: (2023)

Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis
by: Helena Castañé, et al.
Published: (2023)

Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview
by: Débora Levy, et al.
Published: (2019)

Paraoxonase Role in Human Neurodegenerative Diseases
by: Cadiele Oliana Reichert, et al.
Published: (2020)

World kidney day 2018; chronic kidney disease in women
by: Mehrdad Zahmatkesh, et al.
Published: (2018)

EFFECT OF LOW-DOSE NIACIN ON DYSLIPIDEMIA, SERUM PHOSPHORUS LEVELS AND ADVERSE EFFECTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: Won Suk An, et al.
Published: (2012)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Gian Luca Erre, et al.
Published: (2022)

Effects of thymoquinone and the curcumin analog EF-24 on the activity of the enzyme paraoxonase-1 in human glioblastoma cells U87MG
by: Ender Simsek, et al.
Published: (2024)

Paraoxonase Activities in Metabolic Syndrome in Children and Adolescents
by: Arati Adhe-Rojekar, et al.
Published: (2018)

Phytochemicals as Modulators of Paraoxonase-1 in Health and Diseases
by: Zahra Najafi Arab, et al.
Published: (2022)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia
by: Arianna Romani, et al.
Published: (2020)

Administration of antioxidants in chronic kidney disease
by: Tamadon Mohamad Reza, et al.
Published: (2015)

Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease
by: Cadiele Oliana Reichert, et al.
Published: (2019)

Lipid Profile and Serum Paraoxonase1 Activity in CRF Patients Pre and Posthemodialysis
by: Nitin S. Nagane1* and Jayshree V. Ganu2
Published: (2011)

Paraoxonase-1 and Other HDL Accessory Proteins in Neurological Diseases
by: Judit Marsillach, et al.
Published: (2021)

The role of plasma angiotensin-converting enzyme and interleukin-6 levels on the prognosis of non-dialysis chronic kidney disease patients
by: Budi Susetyo Pikir, et al.
Published: (2023)

Serum Paraoxonase-1 Activity and the Risk of Prostate Cancer Recurrence in Patients Treated with Radiotherapy
by: Milosz Jasinski, et al.
Published: (2022)

Dyslipidemia in active juvenile dermatomyositis patients
by: Viana VST, et al.
Published: (2011)

Lecithin-cholesterol acyltransferase and paraoxonase-1 levels in atherosclerotic cardiovascular disease patients in Nigeria
by: Promise C. Nwaejigh, et al.
Published: (2024)

Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019)

Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019)

The Relationship between Cancer and Paraoxonase 1
by: Irma Martha Medina-Díaz, et al.
Published: (2022)

The Use of angiotensin converting enzyme inhibitors in chronic kidney disease - a review of the literature
by: Jakub Sosnowski, et al.
Published: (2023)

Physical activity of patients with chronic kidney disease
by: Klaudia Marczyk, et al.
Published: (2023)

Paraoxonase I Activity and Its Relationship with Nutrition in Amyotrophic Lateral Sclerosis
by: Belén Proaño, et al.
Published: (2024)

Paraoxonase-1 activity in type 2 diabetes mellitus with and without nephropathy
by: Nehal H El-said, et al.
Published: (2015)

OBESITY AND DYSLIPIDEMIA IN CHILDREN WITH CHRONIC HEPATITIS
by: Alice N. Azoicai, et al.
Published: (2016)

Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease
by: Jolanta Parada-Turska, et al.
Published: (2020)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020)

Paraoxonase-1 and Early-Life Environmental Exposures
by: Judit Marsillach, et al.
Published: (2016)

Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis
by: Oriana Simonetti, et al.
Published: (2021)

Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
by: Vanwong N, et al.
Published: (2022)

Dyslipidemia in coronavirus disease 2019 pneumonia patients
by: Peng Cao, et al.
Published: (2020)